Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin
Abstract Background The CDSCO of India has authorized a combination of metformin hydrochloride, teneligliptin hydrochloride, and pioglitazone hydrochloride for the treatment of insulin-independent diabetes. For the purpose of estimating metformin, teneligliptin, and pioglitazone combinations as well...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SpringerOpen
2024-11-01
|
| シリーズ: | Future Journal of Pharmaceutical Sciences |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s43094-024-00746-7 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|